ResearcherWashington University in St. LouisActive in the last 2 years
Marcus Chuan Beng Tan
Matched on ORCID iD 0000-0003-0698-3936; OpenAlex author ID A5065596046. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diab… Co-author DOI 10.1016/j.ebiom.2024.105233↗
- Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer. Co-author DOI 10.3390/cancers14020283↗
- Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/jgo.2018.07.02↗
- Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. Co-author DOI 10.1016/j.hpb.2017.01.012↗
- Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Co-author DOI 10.2174/156800911796191024↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chan Shen · 1 shared paper, 2022 · strength 0.15
- Michael Brian LaPelusa · 1 shared paper, 2022 · strength 0.15
- Cathy Eng · 1 shared paper, 2022 · strength 0.15
- Dana Backlund Cardin · 1 shared paper, 2022 · strength 0.15
- Jordan D. Berlin · 1 shared paper, 2022 · strength 0.15
- A. Bapsi Chakravarthy · 1 shared paper, 2022 · strength 0.15
- David C. Linehan · 2 shared papers, 2011–2017 · strength 0.10
- Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
- Paper Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. DOI 10.2174/156800911796191024↗
- William G. Hawkins · 2 shared papers, 2011–2017 · strength 0.10
- Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
- Paper Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. DOI 10.2174/156800911796191024↗
- Kerri A. Ohman · 1 shared paper, 2017 · strength 0.07
- Steven M. Strasberg · 1 shared paper, 2017 · strength 0.07
- Benjamin R. Tan · 1 shared paper, 2017 · strength 0.07
- Ryan C Fields · 1 shared paper, 2017 · strength 0.07
- Seema Singh · 1 shared paper, 2019 · strength 0.07
- Mary C. Patton · 1 shared paper, 2019 · strength 0.07
- Arun Bhardwaj · 1 shared paper, 2019 · strength 0.07
- Moh'd M. Khushman · 1 shared paper, 2019 · strength 0.07
- Girijesh Kumar Patel · 1 shared paper, 2019 · strength 0.07
- Ajay P. Singh · 1 shared paper, 2019 · strength 0.07
- Peter S. Goedegebuure · 1 shared paper, 2011 · strength 0.03
- Matthew R. Porembka · 1 shared paper, 2011 · strength 0.03
- Andrea Wang‐Gillam · 1 shared paper, 2011 · strength 0.03
- William E. Gillanders · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.